CMEA Capital, based in San Francisco, is a venture capital firm that specializes in investments in life sciences, high technology, and alternative energy. Since its founding in 1989, CMEA has focused on both early and late-stage companies that possess cutting-edge technology and experienced management teams. The firm emphasizes the importance of science-based ventures and seeks to partner with entrepreneurs capable of transforming their industries. CMEA manages a substantial portfolio, guided by a network of corporate, investment, and entrepreneurial relationships. With a commitment to innovation and excellence, CMEA Capital has established itself as a significant player in the venture capital landscape, previously operating under the New Enterprise Associates umbrella before becoming independent in 1997.
VYNE Therapeutics Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative therapies for dermatological conditions. It offers AMZEEQ, a topical minocycline treatment for non-nodular moderate-to-severe acne vulgaris in patients aged 9 and older. The company is advancing its pipeline with FMX103, currently in Phase III clinical trials for moderate-to-severe papulopustular rosacea in adults, and FCD105, a topical combination foam under investigation in Phase II trials for moderate-to-severe acne vulgaris. Additionally, VYNE is developing Serlopitant, an oral NK1 receptor antagonist aimed at addressing pruritus associated with prurigo nodularis, as well as exploring therapies for other immuno-inflammatory conditions. Formerly known as Menlo Therapeutics Inc., the company rebranded in September 2020 and is headquartered in Bridgewater, New Jersey.
CNano
Series B in 2015
Cnano Technology Limited specializes in the development and manufacturing of carbon nanotubes and conductive pastes. Founded in 2006 and headquartered in San Francisco, California, the company has advanced research and manufacturing facilities in Beijing, China. Its products find applications across various industries, including energy, automotive, aerospace, and electronics. In the energy sector, Cnano's carbon nanotubes are utilized in batteries, super-capacitors, and fuel cells. The automotive industry benefits from their use in electrostatic paintable polymers and fuel system components. Additionally, Cnano's technology serves structural composites in sporting goods and aerospace, as well as transparent conductive coatings and components in electronics. The company has established a large-scale production technology for carbon nanotubes, leveraging exclusive licensing from Tsinghua University alongside its own innovations.
Jobvite
Series D in 2014
Jobvite is a developer of a recruitment platform and talent acquisition suite designed to assist companies in attracting, engaging, hiring, onboarding, and promoting talent essential for achieving business objectives. The company's candidate-centric recruiting model focuses on providing meaningful experiences for candidates throughout the hiring process, from initial contact to their first day. Jobvite integrates automation and intelligence into its recruitment applications, enhancing recruiting speed, quality, and cost-effectiveness. This innovative approach enables organizations of various sizes and industries to leverage real-time recruiting intelligence and adapt to the evolving demands of the job market.
Sorbent Therapeutics
Series D in 2014
Sorbent Therapeutics, Inc. develops treatment for end stage renal disease patients undergoing dialysis. The company develops fluid retaining polymers for therapeutic uses, such as treatment of kidney diseases. Sorbent Therapeutics, Inc. was founded in 2005 and is based in Vernon Hills, Illinois.
Arcadia Biosciences
Series D in 2014
Arcadia Biosciences, Inc. is an agricultural technology company based in Davis, California, focusing on the development of crop productivity traits primarily in hemp, wheat, and soybean. Established in 2002, the company employs advanced screening, breeding, and biotechnology techniques to create products that enhance farm economics and improve the value of crops as food ingredients, health and wellness products, and for industrial applications. Its product lineup includes GoodHemp, a range of non-GMO hemp seed varieties aimed at genetic improvement; GoodWheat, which transforms wheat into a functional food; and a drought and herbicide-tolerant soybean trait known as HB4. Additionally, Arcadia Biosciences produces plant-based food and beverage products, including high-fiber pasta and coconut water, thereby catering to consumer demands while promoting environmental sustainability. The company operates in diverse markets, including the United States, Canada, Africa, and India, and collaborates with several industry partners to advance its initiatives.
Neos Therapeutics
Series C in 2014
Neos Therapeutics, Inc. is a pharmaceutical company focused on the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD) using its specialized drug delivery technology. The company's product lineup includes extended-release medications such as Adzenys XR-ODT and Cotempla XR-ODT, both designed for ADHD treatment, along with Adzenys ER and a generic version of Tussionex, which is used for cough relief. Neos also has a clinical-stage product candidate, NT0502, aimed at treating neurological conditions associated with excessive salivation. Established in 2009 and headquartered in Grand Prairie, Texas, Neos Therapeutics operates a state-of-the-art manufacturing facility and emphasizes high-quality products to meet critical medical needs in the United States.
Auspex Pharmaceuticals
Series E in 2014
Auspex Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for orphan diseases, particularly those involving involuntary movement disorders. The company’s pipeline features product candidates aimed at addressing significant unmet medical needs, including hyperkinetic movement disorders such as chorea associated with Huntington’s disease, tardive dyskinesia, and Tourette syndrome. Auspex Pharmaceuticals specializes in creating deuterated analogs of clinically-validated drugs, enhancing existing therapies across various therapeutic areas, including respiratory disease and inflammation. Through its focused approach, the company seeks to provide effective treatment options for patients suffering from these challenging conditions.
MediaSpike
Series A in 2013
MediaSpike, Inc. operates an online platform that specializes in in-game product placement, primarily for social and mobile games. Founded in 2011 and based in Mountain View, California, the company enables advertisers and game developers to collaborate effectively. Developers integrate one of MediaSpike's SDKs to connect with the platform, allowing brands to search for suitable advertising placements based on various criteria through an intuitive dashboard. The process involves selecting placements, uploading assets, previewing the placements, and submitting them for developer approval. Once live, MediaSpike provides analytics to track the performance of these placements, ensuring that both brands and developers can assess the effectiveness of their advertising strategies. The platform also extends its services to virtual reality content, broadening its reach within the gaming industry.
Mojo Networks
Series D in 2013
Mojo Networks, Inc. specializes in developing cloud-managed WiFi solutions for enterprises across various sectors, including education, government, and hospitality. Its offerings include the Mojo Wireless Manager for managing wireless networks, Mojo Guest Manager for guest authentication, and Mojo AirTight, a wireless intrusion prevention system. The company also provides advanced tools such as Mojo Navigator for network design and monitoring, Mojo Aware for leveraging cloud and big data, and Mojo Canvas for creating interactive guest network pages. With a focus on automation and ease of use, Mojo's platform enables seamless management and deployment of WiFi systems without the need for traditional controllers. Founded in 2002 and based in Mountain View, California, Mojo Networks operates as a subsidiary of Arista Networks, enhancing its capabilities in delivering secure and efficient wireless connectivity.
Spitfire Pharma
Venture Round in 2013
Spitfire Pharma, Inc. offers drug development and research services to improve the pharmaceutical properties of peptide drugs. The company was founded in 2011 and is based in South San Francisco, California.
RSI (Reel Solar Inc)
Seed Round in 2013
RSI provides technology, tools, materials and know-how to the leaders in photovoltaic manufacturing. The company has developed a proprietary process for Rapid Efficient Electroplating on Large-areas (REEL). RSI works with regional manufacturing partners to deliver the lowest cost locally manufactured photovoltaic modules. The company was founded in 2009 by a team of capital equipment veterans based in Silicon Valley, California. Co-investors include CalCEF Angel Fund, CMEA, Mayfield Fund, Nth Power, and Pangaea Ventures.
Auspex Pharmaceuticals
Series D in 2012
Auspex Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for orphan diseases, particularly those involving involuntary movement disorders. The company’s pipeline features product candidates aimed at addressing significant unmet medical needs, including hyperkinetic movement disorders such as chorea associated with Huntington’s disease, tardive dyskinesia, and Tourette syndrome. Auspex Pharmaceuticals specializes in creating deuterated analogs of clinically-validated drugs, enhancing existing therapies across various therapeutic areas, including respiratory disease and inflammation. Through its focused approach, the company seeks to provide effective treatment options for patients suffering from these challenging conditions.
MediaSpike
Seed Round in 2012
MediaSpike, Inc. operates an online platform that specializes in in-game product placement, primarily for social and mobile games. Founded in 2011 and based in Mountain View, California, the company enables advertisers and game developers to collaborate effectively. Developers integrate one of MediaSpike's SDKs to connect with the platform, allowing brands to search for suitable advertising placements based on various criteria through an intuitive dashboard. The process involves selecting placements, uploading assets, previewing the placements, and submitting them for developer approval. Once live, MediaSpike provides analytics to track the performance of these placements, ensuring that both brands and developers can assess the effectiveness of their advertising strategies. The platform also extends its services to virtual reality content, broadening its reach within the gaming industry.
WorkingPoint
Venture Round in 2012
WorkingPoint offers an online business management software tailored for small to mid-size companies. The platform provides an integrated solution that encompasses essential functions such as accounting, invoicing, expense and financial reporting, tax reporting, customer relationship management, and inventory management. Designed for ease of use, the web-based software aims to streamline operations, allowing users to efficiently manage their business needs while saving time and resources. By consolidating various business functions into a single platform, WorkingPoint enables clients to effectively oversee their financial and operational tasks.
Luminate
Series C in 2012
Luminate, founded in 2008 and previously known as Pixazza, is a company that specializes in creating interactive image technology. Based in Mountain View, California, Luminate offers a pioneering platform that transforms static images on the web into engaging, interactive content. This platform utilizes a combination of Internet and crowdsourcing technologies to provide users with relevant information and enhance their online experiences, attracting over 150 million users and generating approximately 30 billion image views annually. In addition to its technological innovations, the organization operates as a global philanthropic entity that supports efforts to foster just and fair societies by empowering individuals and institutions. Luminate focuses on four interconnected areas crucial for societal resilience: Civic Empowerment, Data and Digital Rights, Financial Transparency, and Independent Media.
Bionic Panda Games
Seed Round in 2012
Bionic Panda Games, Inc. specializes in the design and development of mobile social games, primarily for the Android platform. Established in 2010 and headquartered in San Francisco, California, the company has built a skilled team with extensive experience in mobile and social gaming. Bionic Panda Games' inaugural title, Aqua Pets, is currently available in the Android Market, showcasing the company's commitment to creating engaging gaming experiences for mobile users.
Graffiti Labs
Seed Round in 2011
Graffiti Labs, Inc. is a company that focuses on developing a browser-based game allowing users to create virtual drawings. Founded in 2007 and headquartered in Newton, Massachusetts, the company has also introduced a Facebook application that enables users to draw for one another, enhancing social interaction through artistic expression.
Zaarly
Series A in 2011
Zaarly, Inc. is an online marketplace that connects small business owners specializing in customer services with homeowners seeking assistance. Founded in 2011 and headquartered in San Francisco, California, Zaarly operates primarily in Denver, Minneapolis, Kansas City, and Northern Virginia. The platform is designed to facilitate home-maintenance jobs and projects, offering features such as selection, communication, scheduling, payment, and reviews. By focusing on a proximity-based, real-time marketplace, Zaarly aims to create a buyer-driven environment that enhances the experience for both service providers and consumers.
Contour Energy
Series C in 2011
Contour Energy is a company of portable power that commercializes customizable battery technologies for a wide range of cross-industry applications. It designs its next-generation battery systems to deliver unprecedented improvements in energy and power density, and are capable of performing in extreme operating conditions at significantly improved costs. Founded through the collaboration of Caltech and CNRS, the French National Center for Scientific Research, It combines expertise in nano-materials science, patented fluorine-based battery chemistries and manufacturing processes to significantly advance the state of portable power. With its headquarters in Azusa in California, a team of battery industry leaders from Caltech, Energizer, General Electric, Hewlett-Packard, Sanyo and Valence Technologies manages it. Private entrepreneurs hold it.
Blekko
Venture Round in 2011
Blekko is a search company established in 2007 by Rich Skrenta and a team from Topix and Netscape's Open Directory. The company offers a web search engine and a mobile application that enables users to filter search results based on specific categories. Additionally, Blekko operates a social news platform to enhance the search experience, allowing users to find relevant information more efficiently. The company has garnered investment from Baseline Ventures and several former Google employees.
Beautylish
Angel Round in 2011
Beautylish, Inc. is an online retailer based in San Francisco, California, specializing in beauty care products. Founded in 2010, the company provides a wide range of items, including makeup, skincare, hair care, fragrance, and beauty tools. Beautylish serves as a social commerce platform that allows users to discover, discuss, and learn about various beauty products. It offers tutorials, tips, and product reviews, enhancing the shopping experience and empowering consumers to make informed choices. By fostering a positive and respectful community, Beautylish aims to create an inclusive space for individuals to explore their beauty preferences.
Ardelyx
Series B in 2011
Ardelyx, Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative oral therapeutics for cardiorenal diseases. Founded in 2007 and headquartered in Fremont, California, the company focuses on addressing significant unmet medical needs through first-in-class medicines. Its lead product candidate, tenapanor, has completed Phase 3 clinical trials for treating irritable bowel syndrome with constipation and hyperphosphatemia in end-stage renal disease patients on dialysis. Additionally, Ardelyx is advancing RDX013, a small molecule potassium secretagogue targeting hyperkalemia, and has other candidates in its pipeline, including RDX002 and RDX009, which are in preclinical development for chronic kidney disease and type 2 diabetes, respectively. Ardelyx employs a proprietary drug discovery platform aimed at creating non-systemic products that target specific transporters and receptors to minimize side effects associated with systemic exposure.
Danotek Motion Technologies
Series B in 2011
Danotek Motion Technologies Inc, founded in 2001, in Ann Arbor, Michigan is an ISO 9001:2000 certified technology innovator. Danotek develops clean, energy efficient, generators, electrical conversion systems, brushless motors and electronics controls for alternative energy and advanced transportation applications. Danotek has developed a number of patent-pending innovative products that include variable speed permanent magnet (PM) generators and brushless motors with integrated electronics for wind power, fuel cell, CHP, auxiliary power and electric and hybrid electric vehicles. Their designs represent industry leadership and are expected to replace inefficient and unreliable systems with added extensive control features.
Sorbent Therapeutics
Series B in 2011
Sorbent Therapeutics, Inc. develops treatment for end stage renal disease patients undergoing dialysis. The company develops fluid retaining polymers for therapeutic uses, such as treatment of kidney diseases. Sorbent Therapeutics, Inc. was founded in 2005 and is based in Vernon Hills, Illinois.
Jobvite
Series C in 2011
Jobvite is a developer of a recruitment platform and talent acquisition suite designed to assist companies in attracting, engaging, hiring, onboarding, and promoting talent essential for achieving business objectives. The company's candidate-centric recruiting model focuses on providing meaningful experiences for candidates throughout the hiring process, from initial contact to their first day. Jobvite integrates automation and intelligence into its recruitment applications, enhancing recruiting speed, quality, and cost-effectiveness. This innovative approach enables organizations of various sizes and industries to leverage real-time recruiting intelligence and adapt to the evolving demands of the job market.
Multigig
Series C in 2010
Multigig, Inc. is a fabless semiconductor company specializing in clock and timing integrated circuits for both wired and wireless communications markets. Headquartered in Scotts Valley, California, the company develops high-performance analog and mixed-signal technologies that address critical system-level timing challenges. Its product lineup includes precision synthesizers, crystal oscillators, and zero delay buffers, all designed to deliver ultra-low jitter and phase noise reference clock signals for a range of applications such as Gigabit Ethernet, SONET/SDH, Fibre Channel, and storage solutions. Founded in 2003, Multigig provides innovative and energy-efficient timing products aimed at the demanding needs of sectors like telecommunications, networking, and computing. As of 2012, it operates as a subsidiary of Analog Devices, Inc.
Auspex Pharmaceuticals
Series C in 2010
Auspex Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for orphan diseases, particularly those involving involuntary movement disorders. The company’s pipeline features product candidates aimed at addressing significant unmet medical needs, including hyperkinetic movement disorders such as chorea associated with Huntington’s disease, tardive dyskinesia, and Tourette syndrome. Auspex Pharmaceuticals specializes in creating deuterated analogs of clinically-validated drugs, enhancing existing therapies across various therapeutic areas, including respiratory disease and inflammation. Through its focused approach, the company seeks to provide effective treatment options for patients suffering from these challenging conditions.
Sorbent Therapeutics
Series B in 2010
Sorbent Therapeutics, Inc. develops treatment for end stage renal disease patients undergoing dialysis. The company develops fluid retaining polymers for therapeutic uses, such as treatment of kidney diseases. Sorbent Therapeutics, Inc. was founded in 2005 and is based in Vernon Hills, Illinois.
Luminate
Series B in 2010
Luminate, founded in 2008 and previously known as Pixazza, is a company that specializes in creating interactive image technology. Based in Mountain View, California, Luminate offers a pioneering platform that transforms static images on the web into engaging, interactive content. This platform utilizes a combination of Internet and crowdsourcing technologies to provide users with relevant information and enhance their online experiences, attracting over 150 million users and generating approximately 30 billion image views annually. In addition to its technological innovations, the organization operates as a global philanthropic entity that supports efforts to foster just and fair societies by empowering individuals and institutions. Luminate focuses on four interconnected areas crucial for societal resilience: Civic Empowerment, Data and Digital Rights, Financial Transparency, and Independent Media.
Baxano
Series C in 2010
Baxano, Inc. specializes in the development of minimally invasive tools aimed at restoring spine function while preserving healthy tissue. Based in San Jose, California, the company offers the iO-Flex System, designed to target and decompress bone and soft tissue in areas such as the foramen, lateral recess, and central canal, catering to patients with varying degrees of stenosis. Its product line includes the Neuro Check device, which enables surgeons to verify that the device is positioned against the bone with the nerve safely out of the way. Additionally, Baxano provides the MicroBlade Shaver instrument for the removal of impinging bone and ligament, along with essential tools like guidewires, probes, and distal handles. Founded in 2005, Baxano continues to innovate in the field of spinal health.
Tetraphase Pharmaceuticals
Series C in 2010
Tetraphase Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel antibiotics to combat serious multidrug-resistant infections. Its primary product candidate, Xerava (eravacycline), is a synthetic fluorocycline designed for intravenous use as a first-line treatment for multidrug-resistant infections, particularly those caused by Gram-negative bacteria. The company has conducted Phase III clinical trials, including IGNITE1 and IGNITE4, to evaluate Xerava's safety and efficacy for treating complicated intra-abdominal infections. In addition to Xerava, Tetraphase is advancing other product candidates, such as TP-271, which targets respiratory diseases caused by antibiotic-resistant pathogens, and TP-6076, aimed at treating multidrug-resistant Gram-negative infections. The company holds a licensing agreement with Everest Medicines Limited to develop and commercialize Xerava in various Asian markets. Founded in 2006 and headquartered in Watertown, Massachusetts, Tetraphase Pharmaceuticals is a subsidiary of La Jolla Pharmaceutical Company.
Contour Energy
Series B in 2010
Contour Energy is a company of portable power that commercializes customizable battery technologies for a wide range of cross-industry applications. It designs its next-generation battery systems to deliver unprecedented improvements in energy and power density, and are capable of performing in extreme operating conditions at significantly improved costs. Founded through the collaboration of Caltech and CNRS, the French National Center for Scientific Research, It combines expertise in nano-materials science, patented fluorine-based battery chemistries and manufacturing processes to significantly advance the state of portable power. With its headquarters in Azusa in California, a team of battery industry leaders from Caltech, Energizer, General Electric, Hewlett-Packard, Sanyo and Valence Technologies manages it. Private entrepreneurs hold it.
CNano
Series B in 2010
Cnano Technology Limited specializes in the development and manufacturing of carbon nanotubes and conductive pastes. Founded in 2006 and headquartered in San Francisco, California, the company has advanced research and manufacturing facilities in Beijing, China. Its products find applications across various industries, including energy, automotive, aerospace, and electronics. In the energy sector, Cnano's carbon nanotubes are utilized in batteries, super-capacitors, and fuel cells. The automotive industry benefits from their use in electrostatic paintable polymers and fuel system components. Additionally, Cnano's technology serves structural composites in sporting goods and aerospace, as well as transparent conductive coatings and components in electronics. The company has established a large-scale production technology for carbon nanotubes, leveraging exclusive licensing from Tsinghua University alongside its own innovations.
Danotek Motion Technologies
Venture Round in 2009
Danotek Motion Technologies Inc, founded in 2001, in Ann Arbor, Michigan is an ISO 9001:2000 certified technology innovator. Danotek develops clean, energy efficient, generators, electrical conversion systems, brushless motors and electronics controls for alternative energy and advanced transportation applications. Danotek has developed a number of patent-pending innovative products that include variable speed permanent magnet (PM) generators and brushless motors with integrated electronics for wind power, fuel cell, CHP, auxiliary power and electric and hybrid electric vehicles. Their designs represent industry leadership and are expected to replace inefficient and unreliable systems with added extensive control features.
Solaria
Debt Financing in 2009
Solaria Corporation specializes in the design, development, and manufacturing of silicon photovoltaic (PV) products, primarily serving solar system integrators, project developers, and large commercial and utility clients across the United States, Europe, and other international markets. The company offers crystalline solar modules tailored for various mounting systems and installation processes, along with tracking systems that enhance energy capture. In addition to its product offerings, Solaria provides services such as preliminary system design, energy yield optimization, and guidance on balance of system costs. The company also supports its clients with technical specifications, installation assistance, troubleshooting, and after-sales services. Founded in 1993 and originally known as Lightchip, Inc., Solaria Corporation is headquartered in Oakland, California, and has additional operations in Germany, India, and China.
Blekko
Series C in 2009
Blekko is a search company established in 2007 by Rich Skrenta and a team from Topix and Netscape's Open Directory. The company offers a web search engine and a mobile application that enables users to filter search results based on specific categories. Additionally, Blekko operates a social news platform to enhance the search experience, allowing users to find relevant information more efficiently. The company has garnered investment from Baseline Ventures and several former Google employees.
Foro Energy
Venture Round in 2009
Foro Energy, Inc. specializes in the development and commercialization of high power laser technology aimed at the oil, natural gas, geothermal, and mining industries. Based in Houston, Texas, the company manufactures advanced laser systems that facilitate drilling and servicing energy wells. Its innovative technology utilizes Stimulated Brillouin Scattering to enhance laser transmission through fiber optic cables, allowing for efficient operation over long distances. Foro Energy also provides a range of supporting components, including optical slip rings and downhole connectors, which are designed to withstand harsh conditions and enable effective energy transfer. Founded in 2008, the company is focused on harnessing laser technology to improve access to geothermal energy and optimize drilling processes in challenging environments.
Jobvite
Series B in 2009
Jobvite is a developer of a recruitment platform and talent acquisition suite designed to assist companies in attracting, engaging, hiring, onboarding, and promoting talent essential for achieving business objectives. The company's candidate-centric recruiting model focuses on providing meaningful experiences for candidates throughout the hiring process, from initial contact to their first day. Jobvite integrates automation and intelligence into its recruitment applications, enhancing recruiting speed, quality, and cost-effectiveness. This innovative approach enables organizations of various sizes and industries to leverage real-time recruiting intelligence and adapt to the evolving demands of the job market.
Blekko
Series C in 2009
Blekko is a search company established in 2007 by Rich Skrenta and a team from Topix and Netscape's Open Directory. The company offers a web search engine and a mobile application that enables users to filter search results based on specific categories. Additionally, Blekko operates a social news platform to enhance the search experience, allowing users to find relevant information more efficiently. The company has garnered investment from Baseline Ventures and several former Google employees.
Schooner Information Technology
Series B in 2009
Schooner Information Technology develops and markets two software products: SchoonerSQL™, a high-availability high-performance SQL database, 100% compatible with standard MySQL and InnoDB, for demanding mission-critical applications; and Membrain™, a 100% memcached-compatible flash-optimized software cache and NoSQL key-value store. SchoonerSQL and Membrain provide industry-leading 99.999% availability with auto fail-over, guarantee no data loss and no stale data”, deliver industry-leading performance and scalability on commodity servers and storage, radically simplify administration, and minimize your Total Cost of Ownership (TCO). Schooner, based in Sunnyvale, CA, is funded by CMEA Capital (Jim Watson), Redpoint Ventures (John Walecka), and Menlo Ventures (Mark Siegel). Learn more at www.schoonerinfotech.com.
Intellikine
Series B in 2009
Intellikine is engaged in the discovery and development of small molecule therapies that specifically target the PI3K/Akt/mTOR signaling pathway. The company focuses on creating innovative drug candidates aimed at treating various conditions, including cancer, inflammation, and autoimmune disorders. Its product lineup features INK128, an orally available TORC1/2 inhibitor designed for solid tumor malignancies, and INK1197, a dual PI3K selective inhibitor intended for patients suffering from immune-mediated inflammatory diseases like rheumatoid arthritis and asthma. Intellikine is dedicated to assembling a talented team and an effective discovery platform to accelerate the development of next-generation medical breakthroughs in kinase inhibitor therapies.
Visiogen
Series D in 2009
Visiogen, Inc. is an ophthalmic medical device company focused on developing innovative vision solutions for patients with cataracts, including those with presbyopia. The company's flagship product is the Synchrony dual optic accommodating intraocular lens (IOL), designed to deliver a seamless range of near, intermediate, and distance vision without the need for glasses or contact lenses. This advanced device is supplied in a pre-loaded injector to minimize lens handling during surgical procedures. Visiogen's technology has received CE Mark approval in Europe and is currently in clinical trials in the United States, aiming to enhance the quality of life for cataract patients through improved vision correction options.
Pyxis Technology
Series C in 2009
Pyxis Technology specializes in developing advanced analog routing engines tailored for the complexities of nanoscale integrated circuit (IC) designs. The company offers integrated circuit routing software for both full-custom and semi-custom IC designs, including products like NexusRoute-SoC, which focuses on yield-aware routing for system-on-chip applications, and NexusRoute-HPC, designed to give users control over routing constraints for hierarchical custom designs. Pyxis Technology enhances custom design automation by integrating analysis tools that allow for comprehensive "what-if" explorations in custom analog design. Additionally, the company is set to integrate its technology into Mentor’s IC Station, which will introduce advanced automated analog routing capabilities not currently available in the market.
Ambrx
Series D in 2009
Ambrx, Inc. is a clinical-stage biopharmaceutical company based in La Jolla, California, that specializes in the development of engineered precision biologics using an advanced genetic code technology platform. This innovative approach enables the incorporation of synthetic amino acids into proteins, leading to the creation of next-generation therapeutics, including antibody drug conjugates (ADCs), bispecific antibodies, and long-acting therapeutic peptides. Ambrx's development pipeline features several product candidates, such as ARX788, ARX517, and ARX305, which target various therapeutic areas, including oncology, metabolic, and cardiovascular diseases. The company collaborates with organizations like MabSpace Biosciences, BeiGene, and NovoCodex Biopharmaceuticals to enhance its research and development efforts. Founded in 2003, Ambrx aims to optimize the efficacy, safety, and usability of its biopharmaceutical products.
Luminate
Series A in 2009
Luminate, founded in 2008 and previously known as Pixazza, is a company that specializes in creating interactive image technology. Based in Mountain View, California, Luminate offers a pioneering platform that transforms static images on the web into engaging, interactive content. This platform utilizes a combination of Internet and crowdsourcing technologies to provide users with relevant information and enhance their online experiences, attracting over 150 million users and generating approximately 30 billion image views annually. In addition to its technological innovations, the organization operates as a global philanthropic entity that supports efforts to foster just and fair societies by empowering individuals and institutions. Luminate focuses on four interconnected areas crucial for societal resilience: Civic Empowerment, Data and Digital Rights, Financial Transparency, and Independent Media.
Superprotonic
Series C in 2009
Superprotonic is an energy technology company established to market and commercialize the innovative solid acid fuel cell (SAFC) technology developed and patented by the company's founders at the California Institute of Technology. Solid acid fuel cells offer significant cost and performance advantages compared to other fuel cell technologies currently under development.
Intermolecular
Series D in 2009
Intermolecular, Inc. specializes in the development of advanced materials through its high productivity combinatorial (HPC) technology platform, targeting various industries such as semiconductors, consumer electronics, automotive, and aerospace. The company's HPC platform includes the Tempus processing tools, automated characterization methods, and informatics analysis software, which facilitate materials discovery and process development. Intermolecular's offerings encompass wet workflow systems for self-assembly, electroless deposition, and surface preparation, as well as atomic layer deposition (ALD) and physical vapor deposition (PVD) systems. The company serves a diverse range of markets, including semiconductor, biotechnology, and energy sectors, with a significant focus on the Asia-Pacific region. Founded in 2004 and headquartered in San Jose, California, Intermolecular operates as a subsidiary of MERCK Kommanditgesellschaft auf Aktien.
Contour Energy
Series A in 2008
Contour Energy is a company of portable power that commercializes customizable battery technologies for a wide range of cross-industry applications. It designs its next-generation battery systems to deliver unprecedented improvements in energy and power density, and are capable of performing in extreme operating conditions at significantly improved costs. Founded through the collaboration of Caltech and CNRS, the French National Center for Scientific Research, It combines expertise in nano-materials science, patented fluorine-based battery chemistries and manufacturing processes to significantly advance the state of portable power. With its headquarters in Azusa in California, a team of battery industry leaders from Caltech, Energizer, General Electric, Hewlett-Packard, Sanyo and Valence Technologies manages it. Private entrepreneurs hold it.
Symwave
Series C in 2008
Symwave specializes in the design, development, and marketing of high-performance analog and mixed-signal integrated circuits and system solutions. The company focuses on fast-growing applications that require rapid data transfer, such as external storage devices, portable phones, media players, and HD camcorders. Its product lineup includes standards-based serial physical layer integrated circuits and low power analog front end semiconductor solutions, which support multi-gigabit per second data transfer rates with minimal power consumption. Symwave is advancing its technology by developing a range of SuperSpeed USB products, which offer speeds up to five gigabits per second, significantly faster than USB 2.0 while ensuring compatibility with existing USB devices. Additionally, the company provides connectivity solutions for various applications, including video, sound, and data transmission in homes, vehicles, and office environments.
Solyndra
Series E in 2008
Solyndra is a manufacturer of cylindrical panels utilizing CIGS thin-film solar cell technology, located in Fremont, California. Established in 2005, the company focuses on designing and producing photovoltaic systems that include both panels and mounting hardware specifically for the commercial rooftop market. Solyndra employs high-volume manufacturing techniques to address the needs of the global solar industry. Its proprietary cylindrical modules are engineered to achieve low installation costs while maximizing solar energy output, particularly on low-slope commercial rooftops. The company operates a fully-automated manufacturing facility spanning 300,000 square feet, underscoring its commitment to efficiency and innovation in solar technology.
Danotek Motion Technologies
Series A in 2008
Danotek Motion Technologies Inc, founded in 2001, in Ann Arbor, Michigan is an ISO 9001:2000 certified technology innovator. Danotek develops clean, energy efficient, generators, electrical conversion systems, brushless motors and electronics controls for alternative energy and advanced transportation applications. Danotek has developed a number of patent-pending innovative products that include variable speed permanent magnet (PM) generators and brushless motors with integrated electronics for wind power, fuel cell, CHP, auxiliary power and electric and hybrid electric vehicles. Their designs represent industry leadership and are expected to replace inefficient and unreliable systems with added extensive control features.
Evolution Robotics
Series B in 2008
Evolution Robotics, Inc. specializes in developing robotics solutions and collaborates with original equipment manufacturers to enhance their products with advanced technologies. The company focuses on creating autonomous robots for both commercial and consumer applications, as well as integrating intelligent functionalities into electronic devices. A key offering is the ERSP®, a software development platform that serves as a foundational infrastructure for robotic application development. This platform includes essential capabilities such as computer vision, navigation, path planning, and human-robot interaction, allowing partnering companies to concentrate on innovative product development while utilizing cutting-edge tools.
Triporati
Venture Round in 2008
Triporati, Inc. is an online travel company based in San Francisco, California, that specializes in helping consumers identify suitable vacation destinations through its unique "Destination Genome Project" platform. This platform leverages the expertise of over 70 travel professionals who have analyzed more than 2,000 destinations worldwide, evaluating them across 62 different attributes and activities. Users can input their interests and receive personalized recommendations, including customized maps that highlight ideal locations for their specific preferences. In addition to offering destination insights, Triporati's website supports travel and non-travel advertisers in reaching an audience of leisure travelers. The company was incorporated in 2008 and aims to simplify the travel planning process for its users.
Schooner Information Technology
Series A in 2008
Schooner Information Technology develops and markets two software products: SchoonerSQL™, a high-availability high-performance SQL database, 100% compatible with standard MySQL and InnoDB, for demanding mission-critical applications; and Membrain™, a 100% memcached-compatible flash-optimized software cache and NoSQL key-value store. SchoonerSQL and Membrain provide industry-leading 99.999% availability with auto fail-over, guarantee no data loss and no stale data”, deliver industry-leading performance and scalability on commodity servers and storage, radically simplify administration, and minimize your Total Cost of Ownership (TCO). Schooner, based in Sunnyvale, CA, is funded by CMEA Capital (Jim Watson), Redpoint Ventures (John Walecka), and Menlo Ventures (Mark Siegel). Learn more at www.schoonerinfotech.com.
Tetraphase Pharmaceuticals
Series A in 2008
Tetraphase Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel antibiotics to combat serious multidrug-resistant infections. Its primary product candidate, Xerava (eravacycline), is a synthetic fluorocycline designed for intravenous use as a first-line treatment for multidrug-resistant infections, particularly those caused by Gram-negative bacteria. The company has conducted Phase III clinical trials, including IGNITE1 and IGNITE4, to evaluate Xerava's safety and efficacy for treating complicated intra-abdominal infections. In addition to Xerava, Tetraphase is advancing other product candidates, such as TP-271, which targets respiratory diseases caused by antibiotic-resistant pathogens, and TP-6076, aimed at treating multidrug-resistant Gram-negative infections. The company holds a licensing agreement with Everest Medicines Limited to develop and commercialize Xerava in various Asian markets. Founded in 2006 and headquartered in Watertown, Massachusetts, Tetraphase Pharmaceuticals is a subsidiary of La Jolla Pharmaceutical Company.
Amitive
Series A in 2008
Amitive Inc. offers on demand supply chain management technology via internet to small and medium-sized companies and operating units of corporations. The company was formerly known as Mitrix Inc. and changed its name to Amitive Inc. in 2008. Amitive Inc. is headquartered in San Mateo, California. Amitive Inc. operates as a subsidiary of Mitsui & Co. (U.S.A.), Inc.
Ardelyx
Series A in 2008
Ardelyx, Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative oral therapeutics for cardiorenal diseases. Founded in 2007 and headquartered in Fremont, California, the company focuses on addressing significant unmet medical needs through first-in-class medicines. Its lead product candidate, tenapanor, has completed Phase 3 clinical trials for treating irritable bowel syndrome with constipation and hyperphosphatemia in end-stage renal disease patients on dialysis. Additionally, Ardelyx is advancing RDX013, a small molecule potassium secretagogue targeting hyperkalemia, and has other candidates in its pipeline, including RDX002 and RDX009, which are in preclinical development for chronic kidney disease and type 2 diabetes, respectively. Ardelyx employs a proprietary drug discovery platform aimed at creating non-systemic products that target specific transporters and receptors to minimize side effects associated with systemic exposure.
Multigig
Series B in 2008
Multigig, Inc. is a fabless semiconductor company specializing in clock and timing integrated circuits for both wired and wireless communications markets. Headquartered in Scotts Valley, California, the company develops high-performance analog and mixed-signal technologies that address critical system-level timing challenges. Its product lineup includes precision synthesizers, crystal oscillators, and zero delay buffers, all designed to deliver ultra-low jitter and phase noise reference clock signals for a range of applications such as Gigabit Ethernet, SONET/SDH, Fibre Channel, and storage solutions. Founded in 2003, Multigig provides innovative and energy-efficient timing products aimed at the demanding needs of sectors like telecommunications, networking, and computing. As of 2012, it operates as a subsidiary of Analog Devices, Inc.
Untangle
Series B in 2008
Untangle, Inc. is a provider of cybersecurity software solutions and appliances tailored for small-to-medium businesses. The company offers a range of products, including its NG Firewall, which balances performance, protection, and productivity needs, as well as NG Firewall appliances, Command Center for centralized management, and ScoutIQ, a cloud service. Its solutions address various cybersecurity concerns such as web filtering, Internet of Things security, ransomware protection, and mobile policy enforcement. Untangle serves a diverse clientele, including K-12 schools, higher education institutions, government organizations, nonprofits, and various sectors like healthcare and finance. The company, originally founded as Metavize, Inc. in 1997, rebranded to Untangle in December 2006 and is headquartered in San Jose, California. With its user-friendly, cost-effective solutions, Untangle has established a significant presence, protecting over 2 million users across more than 30,000 organizations worldwide.
SpikeSource
Series C in 2008
SpikeSource is a software certification company that specializes in open source solutions. The company offers a platform designed to assemble, test, package, certify, and update open source, proprietary, and hybrid software. This platform aids independent software vendors (ISVs), independent developers, and IT departments by ensuring interoperability, scalability, and performance of their applications. Additionally, SpikeSource is partnered with Intel and manages the certification process for applications within the Intel Business Exchange, further enhancing its role in the software certification landscape.
NuScale Power
Venture Round in 2008
NuScale Power, LLC specializes in the design, manufacturing, and commercialization of pressurized water reactor nuclear power plants, focusing on small modular reactors that operate independently in multi-module configurations. The company’s technology, developed through extensive research and collaboration with U.S. government support, aims to provide safe, scalable, and efficient energy solutions. NuScale's power systems are applicable in various sectors, including electricity generation, district heating, desalination, hydrogen production, and process heat applications. Founded in 2007 and headquartered in Portland, Oregon, NuScale also has offices in several locations across the United States and the United Kingdom. The company maintains a strategic partnership with Sargent & Lundy and operates as a subsidiary of Fluor Enterprises, Inc.
Luminus Devices
Series E in 2008
Luminus Devices is a developer and manufacturer of high-performance solid-state lighting solutions, focusing on its patented PhlatLight LED technology. This innovative technology offers high light output and versatility, enabling a wide range of applications in the global illumination market, including projection displays, entertainment, and general lighting. Luminus Devices aims to redefine the solid-state lighting landscape by creating advanced lighting products that were previously deemed impossible with traditional lighting technologies. Their PhlatLight LEDs are utilized by leading global companies in diverse consumer and specialty markets.
InSound Medical
Series E in 2008
InSound Medical, Inc. is a privately held company located in Newark, California, specializing in the development and manufacture of advanced hearing solutions. The company is backed by prominent investors such as Johnson & Johnson, DeNovo Ventures, CMEA Ventures, and Psilos Group Managers, LLC. InSound Medical's flagship product is Lyric, an innovative invisible extended wear hearing device designed to provide users with a discreet and effective hearing solution.
TrueDemand Software
Series C in 2008
TrueDemand Software, Inc., founded in 2004 and based in Los Gatos, California, specializes in supply chain solutions. The company's software is designed to enhance retail operations by automatically detecting and predicting out-of-stock items, as well as providing demand forecasting, inventory correction, and sales measurement. By leveraging these capabilities, TrueDemand Software helps retailers optimize their inventory management and improve overall store performance. As of December 2009, it operates as a subsidiary of Acosta, Inc.
Jobvite
Series A in 2007
Jobvite is a developer of a recruitment platform and talent acquisition suite designed to assist companies in attracting, engaging, hiring, onboarding, and promoting talent essential for achieving business objectives. The company's candidate-centric recruiting model focuses on providing meaningful experiences for candidates throughout the hiring process, from initial contact to their first day. Jobvite integrates automation and intelligence into its recruitment applications, enhancing recruiting speed, quality, and cost-effectiveness. This innovative approach enables organizations of various sizes and industries to leverage real-time recruiting intelligence and adapt to the evolving demands of the job market.
Relypsa
Series A in 2007
Relypsa, Inc. is a biopharmaceutical company based in Redwood City, California, specializing in the development and commercialization of late-stage medicines for conditions primarily in the iron deficiency, nephrology, and cardio-renal therapeutic areas. The company is known for its product VELTASSA, a potassium binder designed to treat hyperkalemia. Relypsa focuses on discovering and developing non-absorbed polymeric drugs that address cardiovascular and renal diseases, particularly conditions that are often overlooked or undertreated. Established in 2007, Relypsa operates as a subsidiary of Vifor Pharma Ltd.
Netbooks
Series A in 2007
NetBooks provides online tools that help businesses with their marketing, sales, operations and financial activities.
CNano
Series A in 2007
Cnano Technology Limited specializes in the development and manufacturing of carbon nanotubes and conductive pastes. Founded in 2006 and headquartered in San Francisco, California, the company has advanced research and manufacturing facilities in Beijing, China. Its products find applications across various industries, including energy, automotive, aerospace, and electronics. In the energy sector, Cnano's carbon nanotubes are utilized in batteries, super-capacitors, and fuel cells. The automotive industry benefits from their use in electrostatic paintable polymers and fuel system components. Additionally, Cnano's technology serves structural composites in sporting goods and aerospace, as well as transparent conductive coatings and components in electronics. The company has established a large-scale production technology for carbon nanotubes, leveraging exclusive licensing from Tsinghua University alongside its own innovations.
Mojo Networks
Series C in 2007
Mojo Networks, Inc. specializes in developing cloud-managed WiFi solutions for enterprises across various sectors, including education, government, and hospitality. Its offerings include the Mojo Wireless Manager for managing wireless networks, Mojo Guest Manager for guest authentication, and Mojo AirTight, a wireless intrusion prevention system. The company also provides advanced tools such as Mojo Navigator for network design and monitoring, Mojo Aware for leveraging cloud and big data, and Mojo Canvas for creating interactive guest network pages. With a focus on automation and ease of use, Mojo's platform enables seamless management and deployment of WiFi systems without the need for traditional controllers. Founded in 2002 and based in Mountain View, California, Mojo Networks operates as a subsidiary of Arista Networks, enhancing its capabilities in delivering secure and efficient wireless connectivity.
Phenomix
Series C in 2007
As of October 2010, Phenomix closed down as it was unable to find a partner to pay for is clinical trial bills after Forest Laboratories walked away. Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases. Phenomix' lead clinical candidate, PHX1149, is a DPP4 inhibitor in phase 2 testing as a once daily oral treatment for type 2 diabetes. Phenomix' second program is directed at the treatment of hepatitis C through inhibition of the NS3/4A viral protease. Phenomix is based in San Diego, California.
LiveOps
Series C in 2007
LiveOps, Inc. is a provider of cloud-based multi-channel solutions designed for customer engagement across various industries, including finance, healthcare, insurance, retail, and technology. Founded in 2000 and headquartered in Scottsdale, Arizona, the company offers a range of services such as LiveOps Chat for real-time customer interaction, an on-demand outsourced call center solution, and a comprehensive email system that gives agents a complete view of customer interactions. LiveOps also features Skill Builder, a customizable training program to enhance the skills of customer service agents. The company specializes in delivering an on-demand workforce of skilled virtual agents, enabling clients to efficiently scale their customer service operations while minimizing overhead costs. LiveOps serves over 400 organizations, providing faster program readiness and improved customer satisfaction compared to traditional call centers.
Telsima
Venture Round in 2007
Telsima Corp. specializes in the development and marketing of base station and subscriber station systems, along with network management software specifically designed for the WiMAX telecommunications market. Founded in 1999 and based in Sunnyvale, California, the company has additional offices in India and Slovenia. Telsima offers a range of products, including mobile WiMAX solutions such as the StarMAX 6400 macro base station, which enables triple play services over mobile broadband, and the StarMAX 5200 Pico base station, aimed at underserved areas. Their offerings also include the StarMAX ASN-GW for mobile WiMAX networks and TRUFLE ASN, tailored for operators that do not require roaming features. Through these solutions, Telsima aims to enhance broadband wireless access and mobility for a variety of users.
Untangle
Series A in 2006
Untangle, Inc. is a provider of cybersecurity software solutions and appliances tailored for small-to-medium businesses. The company offers a range of products, including its NG Firewall, which balances performance, protection, and productivity needs, as well as NG Firewall appliances, Command Center for centralized management, and ScoutIQ, a cloud service. Its solutions address various cybersecurity concerns such as web filtering, Internet of Things security, ransomware protection, and mobile policy enforcement. Untangle serves a diverse clientele, including K-12 schools, higher education institutions, government organizations, nonprofits, and various sectors like healthcare and finance. The company, originally founded as Metavize, Inc. in 1997, rebranded to Untangle in December 2006 and is headquartered in San Jose, California. With its user-friendly, cost-effective solutions, Untangle has established a significant presence, protecting over 2 million users across more than 30,000 organizations worldwide.
Kalypsys
Series C in 2006
Kalypsys specializes in pathway-based drug discovery and development services. The company conducts discovery programs across a wide range of therapeutic areas, leveraging its automated and integrated suite of technologies in biology, chemistry, and informatics. By utilizing advanced methodologies, Kalypsys aims to enhance the efficiency and effectiveness of the drug discovery process, ultimately contributing to the development of innovative therapies.
Alien Technology
Venture Round in 2006
Alien Technology Corporation specializes in the manufacture and supply of radio frequency identification (RFID) products and services, particularly focusing on ultra-high frequency (UHF) solutions. Established in 1994 and headquartered in San Jose, California, the company produces a range of UHF passive RFID components, including transceiver chips, tags, antennas, inlays, and readers, utilizing a patented Fluidic Self Assembly (FSA) process for efficient production. Alien Technology's offerings extend to professional services such as item tagging, technical consulting, project management, and system configuration, supporting various industries including retail, logistics, healthcare, and manufacturing. The company operates internationally, with additional offices in regions such as China, Europe, and Australia, and maintains a solutions center in Dayton, Ohio. Alien Technology is recognized for its commitment to reliable and cost-effective RFID solutions that enhance supply chain management, inventory control, and anti-counterfeiting efforts across diverse applications.
Strix Systems
Series G in 2006
Strix Systems Inc. specializes in designing and manufacturing wireless mesh networking solutions. The company offers a range of products, including modular mesh systems, outdoor and indoor wireless network equipment, and mobile wireless systems. Its software platform, Manager/One, allows for comprehensive control and management of network configurations. Strix Systems serves various sectors, including public safety, government, energy, transportation, education, and healthcare, providing solutions for both fixed and mobile applications. In addition to its products, the company offers technical support, training, and certification services to assist with deployments. Strix Systems markets its offerings through distributors, service providers, resellers, and systems integrators globally. Founded in 2000, the company is headquartered in Ventura, California, with additional offices in Mumbai and Ahmedabad, India.
Intermolecular
Series C in 2006
Intermolecular, Inc. specializes in the development of advanced materials through its high productivity combinatorial (HPC) technology platform, targeting various industries such as semiconductors, consumer electronics, automotive, and aerospace. The company's HPC platform includes the Tempus processing tools, automated characterization methods, and informatics analysis software, which facilitate materials discovery and process development. Intermolecular's offerings encompass wet workflow systems for self-assembly, electroless deposition, and surface preparation, as well as atomic layer deposition (ALD) and physical vapor deposition (PVD) systems. The company serves a diverse range of markets, including semiconductor, biotechnology, and energy sectors, with a significant focus on the Asia-Pacific region. Founded in 2004 and headquartered in San Jose, California, Intermolecular operates as a subsidiary of MERCK Kommanditgesellschaft auf Aktien.
TrueDemand Software
Series B in 2006
TrueDemand Software, Inc., founded in 2004 and based in Los Gatos, California, specializes in supply chain solutions. The company's software is designed to enhance retail operations by automatically detecting and predicting out-of-stock items, as well as providing demand forecasting, inventory correction, and sales measurement. By leveraging these capabilities, TrueDemand Software helps retailers optimize their inventory management and improve overall store performance. As of December 2009, it operates as a subsidiary of Acosta, Inc.
Codexis
Series D in 2006
Codexis, Inc. is an industrial biotechnology company that specializes in the discovery, development, and commercialization of protein catalysts for pharmaceutical and chemical production through biocatalysis. Founded in 2002 and headquartered in Redwood City, California, Codexis utilizes its proprietary CodeEvolver directed evolution technology platform to create enzyme optimization solutions that enhance process development from research to manufacturing. The company offers a range of products and services, including biocatalysts, enzyme screening, and protein engineering services, which are utilized by over 50 pharmaceutical firms globally. Codexis generates the majority of its revenue through product sales and also licenses its CodeEvolver technology to enable pharmaceutical companies to engineer enzymes for their own production needs. Its customer base spans various markets, including the United States, Europe, and Asia, contributing to the company's growth in the biotechnology sector.
Ambrx
Series C in 2006
Ambrx, Inc. is a clinical-stage biopharmaceutical company based in La Jolla, California, that specializes in the development of engineered precision biologics using an advanced genetic code technology platform. This innovative approach enables the incorporation of synthetic amino acids into proteins, leading to the creation of next-generation therapeutics, including antibody drug conjugates (ADCs), bispecific antibodies, and long-acting therapeutic peptides. Ambrx's development pipeline features several product candidates, such as ARX788, ARX517, and ARX305, which target various therapeutic areas, including oncology, metabolic, and cardiovascular diseases. The company collaborates with organizations like MabSpace Biosciences, BeiGene, and NovoCodex Biopharmaceuticals to enhance its research and development efforts. Founded in 2003, Ambrx aims to optimize the efficacy, safety, and usability of its biopharmaceutical products.
Pyxis Technology
Series B in 2006
Pyxis Technology specializes in developing advanced analog routing engines tailored for the complexities of nanoscale integrated circuit (IC) designs. The company offers integrated circuit routing software for both full-custom and semi-custom IC designs, including products like NexusRoute-SoC, which focuses on yield-aware routing for system-on-chip applications, and NexusRoute-HPC, designed to give users control over routing constraints for hierarchical custom designs. Pyxis Technology enhances custom design automation by integrating analysis tools that allow for comprehensive "what-if" explorations in custom analog design. Additionally, the company is set to integrate its technology into Mentor’s IC Station, which will introduce advanced automated analog routing capabilities not currently available in the market.
AWR Corporation
Venture Round in 2006
AWR Corporation specializes in developing high-frequency electronic design automation (EDA) software aimed at facilitating the design of advanced products such as cell phones and satellite systems. The company offers a range of software solutions, including Microwave Office for designing radio frequency and microwave circuits, Visual System Simulator for architecting communication systems, and Analog Office for managing RFIC and analog designs through various stages of development. AWR's products support the design of a wide array of wireless technologies, including amplifiers, antennas, and filters. The company's innovative technology and flexible software architecture enhance design automation across different vendor tools, thereby improving productivity and efficiency for engineers. Headquartered in El Segundo, California, AWR Corporation operates as a subsidiary of Cadence Design Systems and serves a global customer base with thousands of users.
Perlegen Sciences
Series D in 2006
Perlegen Sciences engages in the discovery and commercialization of genetic variations that provide physicians with information to improve the clinical decision-making process and patient treatment outcomes. Its products include MammaPLUS, a breast cancer risk stratifier and a panel of common genetic variants that stratifies individual genetic and background/clinical risk for those at moderately elevated risk for non-familial breast cancer, as well as impacts the risk for developing invasive breast cancer; and Genotype Browser Website that provides a way to access and view the results of a study of genetic variation in various diverse human populations. Perlegen Sciences, Inc. was founded in 2000 and is based in Mountain View, California.
Telsima
Series C in 2005
Telsima Corp. specializes in the development and marketing of base station and subscriber station systems, along with network management software specifically designed for the WiMAX telecommunications market. Founded in 1999 and based in Sunnyvale, California, the company has additional offices in India and Slovenia. Telsima offers a range of products, including mobile WiMAX solutions such as the StarMAX 6400 macro base station, which enables triple play services over mobile broadband, and the StarMAX 5200 Pico base station, aimed at underserved areas. Their offerings also include the StarMAX ASN-GW for mobile WiMAX networks and TRUFLE ASN, tailored for operators that do not require roaming features. Through these solutions, Telsima aims to enhance broadband wireless access and mobility for a variety of users.
Agility Design Solutions
Series B in 2005
Agility Design Solutions, Inc. develops software tools that shorten the time to design, verify, and implement signal processing algorithms. The company offers solutions for algorithm acceleration, prototyping, and implementation in software and hardware. Its products include RMS, which improves the execution speed of MATLAB programs; MCS, which automatically synthesizes MATLAB code to C code; MCS Function Library, which includes functions that are synthesized using MCS to generate ANSI-C source; DK Design Suite, a design environment for C-based algorithmic design entry, simulation, and synthesis; RC Series Platforms, a family of FPGA-based rapid prototyping/development boards; and PixelStreams Imaging Library, which includes IP cores for digital image and video processing. The company also offers training, support, and algorithm implementation consulting services. It serves customers in various fields, including video analysis, image recognition, and wireless and wired communications. The company markets and sells its products through direct sales channels and local distributors in North America, Asia, and Europe. Agility Design Solutions, Inc. was formerly known as Catalytic, Inc. and changed its name to Agility Design Solutions, Inc. in January, 2008. Agility Design Solutions, Inc. was founded in 2001 and is headquartered in Palo Alto, California with additional offices in Austin, Texas; Abingdon, England; and Yokohama, Japan.
Raven Biotechnologies
Series D in 2005
Raven biotechnologies, Inc., a biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. Its lead product candidate, RAV12, targets adenocarcinomas and used for the treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is based in South San Francisco, California. As of July 17, 2008, Raven Biotechnologies, Inc. operates as a subsidiary of MacroGenics, Inc.
Intermolecular
Series B in 2005
Intermolecular, Inc. specializes in the development of advanced materials through its high productivity combinatorial (HPC) technology platform, targeting various industries such as semiconductors, consumer electronics, automotive, and aerospace. The company's HPC platform includes the Tempus processing tools, automated characterization methods, and informatics analysis software, which facilitate materials discovery and process development. Intermolecular's offerings encompass wet workflow systems for self-assembly, electroless deposition, and surface preparation, as well as atomic layer deposition (ALD) and physical vapor deposition (PVD) systems. The company serves a diverse range of markets, including semiconductor, biotechnology, and energy sectors, with a significant focus on the Asia-Pacific region. Founded in 2004 and headquartered in San Jose, California, Intermolecular operates as a subsidiary of MERCK Kommanditgesellschaft auf Aktien.
Teros
Series D in 2005
Teros, Inc. provides security solutions for companies, government agencies, and large Web site operators. It develops Secure Application Gateway, Teros's FireLine Solution, Web Services, and SAFE modules that protect Web and Web services applications. The Secure Application Gateway is a hardened security appliance, which is deployed directly in the data path of application traffic and blocks attacks that are not detected by network-based firewalls and intrusion detection systems. The Teros's FireLine Solution blocks damaging Web-based attacks and prevents the disclosure of sensitive corporate and customer information. The Web Services allow developers to link business-critical applications to groups of users and applications. The SAFE modules provide defined object protection and deliver the capability of protecting user-defined data objects. The company was formerly known as Stratum8 Networks, Inc. and changed its name to Teros, Inc. in February 2003. The company was founded in 2000 and is based in Santa Clara, California. As of November 15, 2005, Teros Inc. operates as a subsidiary Citrix Systems, Inc.
Perlegen Sciences
Series D in 2005
Perlegen Sciences engages in the discovery and commercialization of genetic variations that provide physicians with information to improve the clinical decision-making process and patient treatment outcomes. Its products include MammaPLUS, a breast cancer risk stratifier and a panel of common genetic variants that stratifies individual genetic and background/clinical risk for those at moderately elevated risk for non-familial breast cancer, as well as impacts the risk for developing invasive breast cancer; and Genotype Browser Website that provides a way to access and view the results of a study of genetic variation in various diverse human populations. Perlegen Sciences, Inc. was founded in 2000 and is based in Mountain View, California.
Intermolecular
Series A in 2004
Intermolecular, Inc. specializes in the development of advanced materials through its high productivity combinatorial (HPC) technology platform, targeting various industries such as semiconductors, consumer electronics, automotive, and aerospace. The company's HPC platform includes the Tempus processing tools, automated characterization methods, and informatics analysis software, which facilitate materials discovery and process development. Intermolecular's offerings encompass wet workflow systems for self-assembly, electroless deposition, and surface preparation, as well as atomic layer deposition (ALD) and physical vapor deposition (PVD) systems. The company serves a diverse range of markets, including semiconductor, biotechnology, and energy sectors, with a significant focus on the Asia-Pacific region. Founded in 2004 and headquartered in San Jose, California, Intermolecular operates as a subsidiary of MERCK Kommanditgesellschaft auf Aktien.
LiveOps
Series B in 2004
LiveOps, Inc. is a provider of cloud-based multi-channel solutions designed for customer engagement across various industries, including finance, healthcare, insurance, retail, and technology. Founded in 2000 and headquartered in Scottsdale, Arizona, the company offers a range of services such as LiveOps Chat for real-time customer interaction, an on-demand outsourced call center solution, and a comprehensive email system that gives agents a complete view of customer interactions. LiveOps also features Skill Builder, a customizable training program to enhance the skills of customer service agents. The company specializes in delivering an on-demand workforce of skilled virtual agents, enabling clients to efficiently scale their customer service operations while minimizing overhead costs. LiveOps serves over 400 organizations, providing faster program readiness and improved customer satisfaction compared to traditional call centers.
Sanera Systems
Venture Round in 2002
At Sanera Systems, Inc. they are building a dream team to deliver innovative, new-paradigm system products. They are a well-funded startup (top tier VCs and visionaries) actively looking to fill positions in software, hardware, and marketing.
Sanera Systems
Series B in 2001
At Sanera Systems, Inc. they are building a dream team to deliver innovative, new-paradigm system products. They are a well-funded startup (top tier VCs and visionaries) actively looking to fill positions in software, hardware, and marketing.
Sanera Systems
Series A in 2000
At Sanera Systems, Inc. they are building a dream team to deliver innovative, new-paradigm system products. They are a well-funded startup (top tier VCs and visionaries) actively looking to fill positions in software, hardware, and marketing.
Syrrx
Series A in 2000
Syrrx Inc is a biotechnology company that specializes in developing novel small molecule drugs aimed at treating cancer, metabolic diseases, and inflammation. The company focuses on drug targets that have been validated in human clinical trials, employing high-throughput structural biology to determine the three-dimensional structures of these targets. This structural insight allows Syrrx to conduct iterative, structure-based drug design programs to efficiently generate potential drug candidates. The company has established partnerships for the development and commercialization of its designed dipeptidyl peptidase IV (DPP IV) inhibitors for treating type 2 diabetes and other significant diseases. Additionally, Syrrx has formed strategic alliances aimed at discovering and early developing inhibitors that target human histone deacetylases (HDACs) and 11β-hydroxysteroid dehydrogenase type 1 (HSD1).
Silicon Spice
Series A in 1997
Silicon Spice, Inc. builds platform solutions that enable networking and telecom system companies to build differentiated access systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.